article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

December 21, 2004. doi:10.1016/S0049-0172(97)80049-2 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice.

article thumbnail

Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes

Drug Topics

They included patients from a large regional hospital in northern Victoria, Australia, who attended the diabetes center from July 2004 to July 2005 for the management of gestational diabetes. The pilot study was aimed at determining diabetes risk reduction behavior when achieving a healthy weight and being physically active.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

A similar inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. Many are still making the transition.

article thumbnail

PQA Welcomes 7 New Members

PQA

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.